Potential of liposomes for the treatment of lung cancer- a review

Potential of liposomes for the treatment of lung cancer- a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiset tiedot
Päätekijä:	Mim, Shanzida
Muut tekijät:	Sheikh, Zara
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2023
Aiheet:	Liposome Lung cancer Aerosol formulation Inhalation54 Lung cancer > Treatment
Linkit:	http://hdl.handle.net/10361/21237

Samankaltaisia teoksia

A review on targeted therapies for lung cancer
Tekijä: Ashraf, Anushey
Julkaistu: (2023)

A review on recent advances in drugs for lung cancer treatment
Tekijä: Noor, Fouzia
Julkaistu: (2024)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Tekijä: Rahman, Tasnim
Julkaistu: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Tekijä: Jeba, Joynob
Julkaistu: (2017)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
Tekijä: Akter, Honufa
Julkaistu: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Tekijä: Pial, Sazia Afrin
Julkaistu: (2018)

Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Tekijä: Tania, Umme
Julkaistu: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Tekijä: Zangmo, Thinley
Julkaistu: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Tekijä: Razna, Amrin Islam
Julkaistu: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Tekijä: Hoque, Ismoth Ara
Julkaistu: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Tekijä: Shabnam, Musharrat
Julkaistu: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Tekijä: Paul, Pulock
Julkaistu: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Tekijä: Nahar, Kamrun
Julkaistu: (2023)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Tekijä: Bristy, Israt Zerin
Julkaistu: (2021)

Breast cancer therapy through Liposomal drug delivery system
Tekijä: Ome, Nusrat Jahan
Julkaistu: (2024)

Lung cancer detection and classification using machine learning
Tekijä: Arefin, Mahbubul, et al.
Julkaistu: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Tekijä: Das, Reshita
Julkaistu: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Tekijä: Mukti, Roushney Fatima, et al.
Julkaistu: (2016)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Tekijä: Muntaha, Habibatul
Julkaistu: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
Tekijä: Khondokar, Faiza
Julkaistu: (2022)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
Tekijä: Rithin, Rafia Islam
Julkaistu: (2022)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Tekijä: Nandy, Aditi
Julkaistu: (2022)

A review on triple-negative breast cancer and its potential treatment
Tekijä: Niasa, Jannatul Ferdous
Julkaistu: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Tekijä: Islam, Saidul
Julkaistu: (2022)

A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024)

Recent advancement on breast cancer detection and treatment
Tekijä: Rahman, Sanjida
Julkaistu: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Karim, Samia Binte
Julkaistu: (2024)

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
Tekijä: Rahman, Qazi Ashrafur
Julkaistu: (2018)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
Tekijä: Ahmed, Kazi Zeba
Julkaistu: (2021)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Tekijä: Alam, Tahera
Julkaistu: (2024)

Targeting BRAFV600E in the treatment of CRC
Tekijä: Roja, Mashwiyat Samrin
Julkaistu: (2024)

Natural products and their combinatory effects in breast cancer treatment
Tekijä: Siddique, Md. Ayman
Julkaistu: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
Tekijä: Alam, Kazi Tasnuva
Julkaistu: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Tekijä: Hossain, Safa Binte
Julkaistu: (2019)